Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 27 Lymphoma, Large B-Cell, Diffuse 10 Lung Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Non-Hodgkin 6 Lymphoma, B-Cell 6 Hodgkin Disease 6 Burkitt Lymphoma 6 Neuroblastoma 5 Medulloblastoma 5 Neoplasms, Germ Cell and Embryonal 4 Leukemia, Myeloid, Acute 4 Small Cell Lung Cancer Extensive Stage 3 Seminoma 3 Retinoblastoma 3 Recurrence 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Carcinoma, Neuroendocrine 3 Brain Neoplasms 3 Wilms Tumor 2 Urinary Bladder Neoplasms 2 Teratoma 2 Sarcoma, Ewing 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Neuroectodermal Tumors, Primitive 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2

Interventions

pembrolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 cemiplimab 2 camrelizumab 2 cabozantinib 2 apatinib 2 Mitotane 2 fludarabine phosphate 1 dostarlimab 1 Megestrol Acetate 1 Interleukin-13 1 Fluorodeoxyglucose F18 1 Floxuridine 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Cisplatin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Adrenocortical Carcinoma × Etoposide × Clear all

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡